Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Osianderstrasse 2-8, Tuebingen, 72076, Germany.
BMC Oral Health. 2023 Sep 25;23(1):688. doi: 10.1186/s12903-023-03391-3.
This study was conducted to determine surgical site infection (SSI) rates and potential risk factors as well as to evaluate antibiotic prophylaxis in orthognathic surgery.
This retrospective observational study included patients who received orthognathic surgery. SSIs and their management were assessed for up to one year post-operatively. The applied antibiotic regime and other possible influencing factors (smoking, age, site of infection, drainage, duration of surgery, displacement distances, craniofacial malformations) were assessed.
In total 291 patient met the inclusion criteria (56.7% female). The mean age at surgery was 25.5 ± 8.5 years. Fifty-four patients (18.6%) were diagnosed with a craniofacial malformation. Relevant previous surgeries were documented in about one quarter of included patients (n = 75). Ninety-two percent of patients (n = 267) received intraoperative single-dose antibiotic prophylaxis. Surgical site infections occurred in 12.4% (n = 36) of patients. There was a significant association between postoperative infections and type of surgery (P = .037) as well as type of drainage (P = .002). Statistical analyses also revealed a higher prevalence of smokers (P = .036) and previous surgically assisted rapid palatal expansion (SARPE) (P = .018) in the infection group. Furthermore, no significant relationships were observed between postoperative infections and various co-factors (i.e. antibiotic regime, age at surgery, gender, associated craniofacial malformations, surgery duration, displacement distances, mandibular setback vs. advancement).
Low rates of SSIs occurred following an intraoperative single-dose antibiotic regime. None of the SSIs had a significant effect on the final surgical outcome. Present data do not warrant escalation of the antibiotic regimen. Postoperative smoking and capillary drainage should be avoided.
本研究旨在确定正颌手术中的手术部位感染(SSI)发生率和潜在风险因素,并评估抗生素预防措施。
本回顾性观察性研究纳入了接受正颌手术的患者。术后长达一年的时间内评估 SSI 及其管理情况。评估了应用的抗生素方案和其他可能的影响因素(吸烟、年龄、感染部位、引流、手术时间、移位距离、颅面畸形)。
共有 291 例患者符合纳入标准(56.7%为女性)。手术时的平均年龄为 25.5±8.5 岁。54 例患者(18.6%)被诊断为颅面畸形。约四分之一的纳入患者(n=75)有相关既往手术史。92%的患者(n=267)接受了术中单次剂量抗生素预防。92%的患者(n=267)接受了术中单次剂量抗生素预防。12.4%(n=36)的患者发生术后感染。术后感染与手术类型(P=0.037)和引流类型(P=0.002)显著相关。统计学分析还显示,感染组吸烟者(P=0.036)和既往接受过手术辅助快速腭扩张术(SARPE)的患者(P=0.018)更为常见。此外,术后感染与各种合并因素(即抗生素方案、手术时年龄、性别、相关颅面畸形、手术持续时间、移位距离、下颌后退与前伸)之间未观察到显著相关性。
术中单次剂量抗生素方案后 SSI 发生率较低。没有一例 SSI 对最终手术结果有显著影响。目前的数据不支持升级抗生素方案。术后吸烟和毛细血管引流应避免。